Tag: Prescription Drugs
Panel Addresses Ezetimibe, PCSK9 Inhibitors for Reducing CV Events
Guideline shifts focus from emphasis on LDL cholesterol targets to individualized approach for lowering overall cardiovascular risk
Orteronel Misses Goal in Metastatic Hormone-Sensitive Prostate Cancer
Significant improvement seen in progression-free survival, but not overall survival, with addition of orteronel to androgen deprivation therapy
Medication Errors Reported Frequently by Home Care Service Nurses
Increased odds of not making medication-related errors found for nurses who had attended training within last two years versus longer period
Fenfluramine Seems Effective for Lennox-Gastaut Syndrome
Reduction in frequency of drop seizures greater with fenfluramine versus placebo
Dapagliflozin Well Tolerated in COVID-19 Patients, Regardless of eGFR
Effects of dapagliflozin on primary and secondary outcomes consistent for those with eGFR <60 and ≥60 mL/min per 1.73 m2
Sulthiame May Be Effective for Treating Obstructive Sleep Apnea
Treatment reduces the number of breathing pauses and promotes oxygenation
Continued Monitoring Needed for Anti-VEGF Therapy in Macular Edema
Substantial improvement observed through month 12, which persisted through month 60, but lessened with fewer treatments
FDA Approves First COVID-19 Treatment for Use in Children
Veklury had already been fully approved to treat people 12 years and older
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
Many Americans have said they cannot find a doctor to prescribe Paxlovid or a pharmacy that has it
Living Guideline Updated for Drug Treatment of COVID-19
Tenth version recommends nirmatrelvir/ritonavir in patients with confirmed COVID-19 who have highest risk for hospitalization
